Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Sheikholeslami

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
International Journal of Endocrinology and Metabolism|December 26, 2018
The Impact of Physical Activity on Non-communicable Diseases: Findings from 20 Years of the Tehran Lipid and Glucose StudySara Sheikholeslami, Arash Ghanbarian, Fereidoun Azizi
Asian Pacific Journal of Cancer Prevention : APJCP|April 1, 2015
RET proto oncogene mutation detection and medullary thyroid carcinoma preventionMarjan Zarif Yeganeh, Sara Sheikholeslami, Mehdi Hedayati
Critical Reviews in Clinical Laboratory Sciences|December 19, 2015
Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancerMehdi Hedayati, Marjan Zarif Yeganeh, Sara Sheikholeslami, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 20, 2015
Skewed mutational spectrum of RET proto-oncogene Exon10 in Iranian patients with medullary thyroid carcinomaMarjan Zarif Yeganeh, Sara Sheikholeslami, Golnoush Dehbashi Behbahani, et al.
Journal of the Neurological Sciences|June 16, 2012
Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosisMahdi Rafiei, Marjan Zarif Yeganeh, Sara Sheikholeslami, et al.
Iranian Journal of Public Health|June 11, 2015
Haplotype Frequency of G691S/S904S in the RET Proto-Onco-gene in Patients with Medullary Thyroid CarcinomaSara Sheikholeslami, Marjan Zarif Yeganeh, Laleh Hoghooghi Rad, et al.
Indian Journal of Surgical Oncology|June 1, 2026
miR-221/222, miR-224, and miR-339 are Overexpressed as Potential Biomarkers in Follicular Thyroid NeoplasmsMahnaz Mohammadi Kian, Jabar Lotfi, Noushin Shabani, et al.
Iranian Journal of Public Health|November 21, 2022
CRISPR/Cas9 <i>RET</i> Gene Knockout in Medullary Thyroid Carcinoma Cell-lines: Optimization and ValidationMarjan Zarif-Yeganeh, Dariush D Farhud, Azam Rahimpour, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|August 28, 2017
Plasma Calcitonin Levels and miRNA323 Expression in Medullary Thyroid Carcinoma Patients with or without RET MutationSamira Ehyaei, Mehdi Hedayati, Marjan Zarif-Yeganeh, et al.
International Journal of Food Sciences and Nutrition|November 3, 2011
Effect of pomegranate seed oil on serum TNF-α level in dyslipidemic patientsGolaleh Asghari, Sara Sheikholeslami, Parvin Mirmiran, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
International Journal of Endocrinology and Metabolism|December 26, 2018
The Impact of Physical Activity on Non-communicable Diseases: Findings from 20 Years of the Tehran Lipid and Glucose StudySara Sheikholeslami, Arash Ghanbarian, Fereidoun Azizi
Asian Pacific Journal of Cancer Prevention : APJCP|April 1, 2015
RET proto oncogene mutation detection and medullary thyroid carcinoma preventionMarjan Zarif Yeganeh, Sara Sheikholeslami, Mehdi Hedayati
Critical Reviews in Clinical Laboratory Sciences|December 19, 2015
Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancerMehdi Hedayati, Marjan Zarif Yeganeh, Sara Sheikholeslami, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 20, 2015
Skewed mutational spectrum of RET proto-oncogene Exon10 in Iranian patients with medullary thyroid carcinomaMarjan Zarif Yeganeh, Sara Sheikholeslami, Golnoush Dehbashi Behbahani, et al.
Journal of the Neurological Sciences|June 16, 2012
Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosisMahdi Rafiei, Marjan Zarif Yeganeh, Sara Sheikholeslami, et al.
Iranian Journal of Public Health|June 11, 2015
Haplotype Frequency of G691S/S904S in the RET Proto-Onco-gene in Patients with Medullary Thyroid CarcinomaSara Sheikholeslami, Marjan Zarif Yeganeh, Laleh Hoghooghi Rad, et al.
Indian Journal of Surgical Oncology|June 1, 2026
miR-221/222, miR-224, and miR-339 are Overexpressed as Potential Biomarkers in Follicular Thyroid NeoplasmsMahnaz Mohammadi Kian, Jabar Lotfi, Noushin Shabani, et al.
Iranian Journal of Public Health|November 21, 2022
CRISPR/Cas9 <i>RET</i> Gene Knockout in Medullary Thyroid Carcinoma Cell-lines: Optimization and ValidationMarjan Zarif-Yeganeh, Dariush D Farhud, Azam Rahimpour, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|August 28, 2017
Plasma Calcitonin Levels and miRNA323 Expression in Medullary Thyroid Carcinoma Patients with or without RET MutationSamira Ehyaei, Mehdi Hedayati, Marjan Zarif-Yeganeh, et al.
International Journal of Food Sciences and Nutrition|November 3, 2011
Effect of pomegranate seed oil on serum TNF-α level in dyslipidemic patientsGolaleh Asghari, Sara Sheikholeslami, Parvin Mirmiran, et al.
Pageof 3